Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Irish

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Biorxiv : the Preprint Server for Biology|August 3, 2021
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA VaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2021
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway InflammationDiana C Contreras Healey, Jacqueline Y Cephus, Sierra M Barone, et al.
Nature Communications|June 17, 2022
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Blood|June 11, 2021
CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplantAlbert C Yeh, Antiopi Varelias, Anupama Reddy, et al.
Annals of Hematology|November 30, 2023
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agentsJan Philipp Bewersdorf, Rory M Shallis, Elad Sharon, et al.
Nature Immunology|March 27, 2025
Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
Blood|June 10, 2016
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatmentShahram Kordasti, Benedetta Costantini, Thomas Seidl, et al.
Hemasphere|May 17, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina A Tentori, Lin P Zhao, Benedetta Tinterri, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2025
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference WorkshopsPaul K Wallace, Evan R Jellison, Sherry Thornton, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Biorxiv : the Preprint Server for Biology|August 3, 2021
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA VaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2021
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway InflammationDiana C Contreras Healey, Jacqueline Y Cephus, Sierra M Barone, et al.
Nature Communications|June 17, 2022
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Blood|June 11, 2021
CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplantAlbert C Yeh, Antiopi Varelias, Anupama Reddy, et al.
Annals of Hematology|November 30, 2023
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agentsJan Philipp Bewersdorf, Rory M Shallis, Elad Sharon, et al.
Nature Immunology|March 27, 2025
Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
Blood|June 10, 2016
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatmentShahram Kordasti, Benedetta Costantini, Thomas Seidl, et al.
Hemasphere|May 17, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina A Tentori, Lin P Zhao, Benedetta Tinterri, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2025
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference WorkshopsPaul K Wallace, Evan R Jellison, Sherry Thornton, et al.
Pageof 10